Identifying the Relationship Between Continuous Glucose Monitor Time in Range and Basal Insulin Adherence in People With Type 2 Diabetes
- 10 November 2024
- journal article
- research article
- Published by SAGE Publications in Journal of Diabetes Science and Technology
- Vol. 20 (2) , 374-380
Abstract
Background: The study aimed to determine the relationship between basal insulin adherence and glycemic control evaluated by time in range (TIR) in people with insulin-treated type 2 diabetes (T2D), using data from both continuous glucose monitors (CGM) and connected insulin pens. Furthermore, the study aimed to determine the best basal insulin adherence metric. Methods: CGM data and basal insulin data were collected from 106 insulin-treated people (aged ≥18 years) with T2D. Three different adherence metrics were employed (dose deviation, dose deviation ≤20%, and a traditional metric) and a three-step methodology was used to measure insulin adherence level. The coefficient of determination (R 2 ), based on a univariate linear regression analysis, was used to determine the relationship between each adherence metric and TIR. Results: A statistically significant relationship was observed between TIR and adherence quantified as the dose deviation ≤20% metric (R 2 = 0.67, P = .006). Neither the relationship between the dose deviation metric and TIR (R 2 = 0.43, P = .08) nor the relationship between the traditional metric and TIR (R 2 = 0.35, P =.23) was found to be statistically significant. Conclusions: Our study indicates a relationship between basal insulin adherence and TIR in people with insulin-treated T2D. This seems to underscore the role of basal insulin adherence for optimal glycemic outcomes and utilizing TIR as a clinical marker. Furthermore, the results suggest that the magnitude of deviation from the recommended basal insulin dose impacts glycemic control, indicating dose deviation ≤20% as a more accurate metric for quantifying adherence.Keywords
This publication has 25 references indexed in Scilit:
- Quantification of insulin adherence in adults with insulin-treated type 2 diabetes: A systematic reviewDiabetes & Metabolic Syndrome: Clinical Research & Reviews, 2023
- Correlation Between Time in Range and HbA1c in People with Type 2 Diabetes on Basal Insulin: Post Hoc Analysis of the SWITCH PRO StudyDiabetes Therapy, 2023
- Use of Connected Pen as a Diagnostic Tool to Evaluate Missed Bolus Dosing Behavior in People with Type 1 and Type 2 DiabetesDiabetes Technology & Therapeutics, 2022
- Timing of Insulin Injections, Adherence, and Glycemic Control in a Multinational Sample of People with Type 2 Diabetes: A Cross-Sectional AnalysisDiabetes Therapy, 2017
- Are patients on basal insulin attaining glycemic targets? Characteristics and goal achievement of patients with type 2 diabetes mellitus treated with basal insulin and physician-perceived barriers to achieving glycemic targetsDiabetes Research and Clinical Practice, 2016
- Measuring insulin adherence among adults with type 2 diabetesJournal of Behavioral Medicine, 2016
- The association between the measurement of adherence to anti-diabetes medicine and the HbA1cInternational Journal of Clinical Pharmacy, 2014
- Proportion of patients at HbA1c target <7% with eight classes of antidiabetic drugs in type 2 diabetes: systematic review of 218 randomized controlled trials with 78 945 patientsDiabetes, Obesity and Metabolism, 2011
- Adherence to insulin and its association with glycaemic control in patients with type 2 diabetesQJM: An International Journal of Medicine, 2007
- Impact of Medication Adherence on Hospitalization Risk and Healthcare CostMedical Care, 2005